-
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
ReLife study general questionnaire
Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months... -
PRIDE Study saliva samples
Single saliva samples for cortisol analyses collected in 2012-2020 in subgroup (N~3400). Partially analyzed, remaining samples stored at -20°C. -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients. -
ReLife study genome-wide germline SNP data
Isolated DNA and genome-wide germline SNP data is available for n=333 patients. -
UroLife study blood samples
EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months... -
ReLife study tissue samples
Permission is available for collection of tumour blocks. -
UroLife study clinical data
Data on tumour characteristics, treatment, and recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer Registry... -
ReLife study accelerometer data
Accelerometer data (ActivPal) is available at 3 (n=346), 12 (n=323) and 24 months (n=271) after surgery. -
ReLife study clinical data
Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer... -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
UroLife study fluid intake and micturition diary
A 4-day fluid and micturition diary was completed at 3 (n=1146) and 15 months (n=1000) after diagnosis. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
UroLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 6 weeks (referring to pre-diagnosis lifestyle; n=1439)) and 3 (n=1316), 15 (n=1143) en 51 months (n<589) after... -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
UroLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis. -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
UroLife study genome-wide germline SNP data
Isolated DNA and genome-wide germline SNP data is available for 1213 patients. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C.